Back

Metabolic, epigenetic and transcriptomic alterations in postnatal 16p11.2 deficient murine astrocytes

Blakeley, N.; Naz, S.; Liu, Z.; Renner, T.; Leclerc, S.; Comin, C. H.; da Silva, M. V.; Vergette, C.; Porter, C. J.; Perkins, T. J.; Lacoste, B.

2025-12-17 cell biology
10.64898/2025.12.16.694710 bioRxiv
Show abstract

Autism Spectrum Disorders (ASD) are associated with metabolic dysregulation. While astrocytes are integral to cerebral metabolism, their molecular and functional changes in ASD are poorly known. Using early postnatal primary cortical astrocytes from a mouse model of 16p11.2 deletion ASD syndrome (16p11.2df/+ mice), we observed core molecular alterations with sex-specific profiles, suggesting divergent energetic pathways and epigenetic regulation. Targeted metabolomics revealed opposing phenotypes in male versus female 16p11.2df/+ astrocytes, particularly for alpha-ketoglutaric acid. Functionally, 16p11.2df/+astrocytes exhibited elevated phosphorylation in low glucose culture conditions, and reduced glycolysis in high glucose. Epigenetic profiling of male 16p11.2df/+astrocytes revealed differentially hydroxymethylated and methylated regions, with foci on chromosomes 3 and 13. Finally, bulk RNA sequencing in male and female mutant astrocytes indicated differential gene expression with profound sex differences, mostly affecting pathways related to cellular morphology. By establishing 16p11.2df/+ astroglial molecular signatures, this study refines our understanding of glial changes in ASD.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.